Lexicon Pharmaceuticals Inc

LXRXNASDAQ NMS - GLOBAL MARKET

Health CarePharmaceuticals

$2.18

-0.030000 (-1.36%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $0.6200Current: $2.1852-Week High: $2.53

Key Statistics

Open

$2.20

Day High

$2.23

Day Low

$2.14

Prev. Close

$2.21

Volume

1.59M

Avg. Volume

—

Market Cap

$968.35M

P/E (TTM)

-31.64

Forward P/E

—

P/B Ratio

—

52W High

$2.53

52W Low

$0.6200

50D MA

$1.84

200D MA

$1.47

Dividend Yield

—

Beta

—

Performance

-2.2%

+40.6%

+54.6%

YTD

+91.2%

+247.9%

About

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets. Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs. Lexicon is pursuing drug targets in five therapeutic areas including oncology, gastroenterology, immunology, metabolism, and ophthalmology.

www.lexpharma.com/